Caribou Biosciences, Inc., 10% Owner at Intellia Therapeutics, Inc. (NTLA), sold 1,101,290 shares at $26.78 ($29.5M) on 2018-01-29, disclosed to the SEC on 2018-01-30.
Open-market sale of $29.5M NTLA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.78 | 550,645 | $14.7M | 50.0% |
| 2 | $26.78 | 550,645 | $14.7M | 50.0% |
| Total | $26.78 avg | 1,101,290 | $29.5M | 100% |